Holen Sie sich die Stockscreener-App
0.61
18.67%
-0.14
Handel nachbörslich:
.65
0.04
+6.56%
Schlusskurs vom Vortag:
$0.75
Offen:
$0.686
24-Stunden-Volumen:
2.19M
Relative Volume:
4.76
Marktkapitalisierung:
$721.96K
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-87.45%
1M Leistung:
-93.48%
6M Leistung:
-98.99%
1J Leistung:
-99.93%
1-Tages-Spanne:
$0.5817
$0.73
1-Wochen-Bereich:
$0.5817
$2.04
52-Wochen-Spanne:
$0.5817
$1,236.24
AEON Biopharma Inc. Stock (AEON) Company Profile
Firmenname
AEON Biopharma Inc.
Sektor
Branche
Telefon
(949) 354-6499
Adresse
5 Park Plaza, Suite 1750, Irvine
Vergleichen Sie AEON mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AEON
AEON Biopharma Inc.
|
0.61 | 721.96K | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
483.31 | 124.35B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
684.87 | 75.07B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
622.61 | 37.96B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
243.53 | 31.79B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
111.56 | 27.34B | 3.30B | -501.07M | 1.03B | -2.1146 |
AEON Biopharma Inc. Stock (AEON) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-08-18 | Eingeleitet | H.C. Wainwright | Buy |
AEON Biopharma Inc. Aktie (AEON) Neueste Nachrichten
AIM ImmunoTech, PepGen, Aeon, Tiziana, Moleculin: 5 Biotech Stocks That Led Retail Message Growth Last Week - Asianet Newsable
AEON Biopharma, Inc. Deloitte, Inc. Announces Update of Phase 2 Double Blind Study of ABP-450 in the Treatment of Migraine - Marketscreener.com
AEON Biopharma Announces Preliminary Top-Line Results from Phase 2 Interim Analysis of ABP-450 in the Preventive Treatment of Chronic Migraine - Marketscreener.com
AEON Biopharma, Inc. Announces Executive Changes -May 16, 2024 at 04:28 pm EDT - Marketscreener.com
AEON Biopharma, Inc. Announces Strategic Reprioritization to Pursue A Biosimilar Pathway for ABP-450 - Marketscreener.com
AEON Biopharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 - Marketscreener.com
Stock market news: AEON Biopharma plummented by 65.33% while Enveric Biosciences skyrocketed by 90.68% during midday trading - Business Upturn
Stock market today: AEON Biopharma plunged by 63.17% while Enveric Biosciences surged by 124.66% in early trading - Business Upturn
AEON Biopharma To Implement 1-for-72 Reverse Stock Split For Compliance With NYSE Rules - Nasdaq
AEON Biopharma executes reverse stock split to comply with NYSE standards - Investing.com Australia
Aeon Biopharma Approves 1-For-72 Reverse Stock Split -February 24, 2025 at 02:53 pm EST - Marketscreener.com
AEON Biopharma shares plunge as it announces reverse stock split - MSN
AEON Biopharma Stockholders Approve Key Proposals - TipRanks
AEON Biopharma, Inc. Announces Reverse Stock Split - The Manila Times
AEON Biopharma Announces 1-for-72 Reverse Stock Split Effective February 26, 2025 - Nasdaq
Can AEON's 1-for-72 Reverse Split Save Its NYSE Listing Status? - StockTitan
AEON Biopharma Inc (AEON) Shares Down Despite Recent Market Volatility - The News Heater
Watch this stock’s price performance: AEON Biopharma Inc (AMEX:AEON) - US Post News
AEON Biopharma Receives Notice Of Non-Compliance With NYSE American Listing Standards - Nasdaq
AEON Biopharma Inc (AMEX: AEON) Could See A Rise In Prices Shortly. - Marketing Sentinel
Investor’s Delight: AEON Biopharma Inc (AEON) Closes Weak at 0.13, Down -6.93 - The Dwinnex
AEON Biopharma receives NYSE non-compliance notice - MSN
AEON Biopharma, Inc. Receives Notice of Non-Compliance with NYSE American Continued Listing Standards - The Manila Times
Aeon Biopharma Gets NYSE American Noncompliance Notice -February 07, 2025 at 05:06 pm EST - Marketscreener.com
Aeon Biopharma Receives Notice Of Non-Compliance With NYSE American Continued Listing Standards - Marketscreener.com
AEON Biopharma Inc [AEON] Stock trading around $0.14 per share: What’s Next? - The DBT News
AEON Biopharma, Inc. Receives Notice of Non-Compliance from NYSE American Due to Stockholders' Deficit - Nasdaq
AEON Biopharma Inc Inc. (AEON) Price Performance: A Comparative Analysis with Competitors - The InvestChronicle
Is AEON Biopharma Inc (AMEX: AEON) Still Trending? - Stocks Register
Take off with AEON Biopharma Inc (AEON): Get ready for trading - SETE News
Analyzing AEON’s current quarter earnings projections - US Post News
Retail Traders Flocked To These 5 Biotech Stocks In January — Here’s Why - Asianet Newsable
AEON Biopharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 - Marketscreener.com
Midday Stock Roundup: FivePoint Holdings Jumps 36% - Orange County Business Journal
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Kairos, OS Therapies, AEON See Highest Weekly Spike In Retail Following Among Biotechs: Here's Why - NewsBreak
Irvine-based Aeon Biopharma Raises $20 Million - Orange County Business Journal
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Dow Jumps Over 300 Points; US Industrial Production Beats Estimates - Benzinga
Why Taiwan Semiconductor Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket - Benzinga
AEON Biopharma Inc (AMEX: AEON) -9.93% Decline Turns Investors Away - Stocks Register
AEON Biopharma (NASDAQ:AEON) Stock Price Down 9.9% – What’s Next? - Defense World
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
AEON Stock Plummets to 52-Week Low at $0.16 Amid Market Turbulence - Investing.com
AEON’s Value Tanks As It Closes $20m Offering Amid Botox Biosimilar Aspirations - News & Insights
AEON Biopharma announces share offering - MSN
AEON Biopharma, Inc. Announces Closing of $20.0 Million Underwritten Public Offering - The Manila Times
AEON Biopharma, Inc. Announces Closing of $20.0 Million Underwritten Public Offering - Benzinga
AEON Biopharma Raises $20M in Public Offering with Dual-Warrant Structure - StockTitan
Form 424B5 AEON Biopharma, Inc. - StreetInsider.com
AEON Biopharma sets $20 million public offering pricing By Investing.com - Investing.com Nigeria
Finanzdaten der AEON Biopharma Inc.-Aktie (AEON)
Es liegen keine Finanzdaten für AEON Biopharma Inc. (AEON) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
6.45%
1.23%
Kapitalisierung:
|
Volumen (24h):